Rigel Pharmaceuticals, Inc.'s 2Q Loss Narrows as Costs Decline

AP -- Rigel Pharmaceuticals Inc. said Tuesday its second-quarter loss narrowed as the development-stage biotechnology company recorded lower expenses and a decline in stock-based compensation.